Why the study?
The study was conducted to determine the correlation between C-reactive protein levels with cognitive function and body mass index in patients with schizophrenia.
Does HsCRP level correlate with cognitive function and BMI in patients with schizophrenia?
Does HsCRP level correlate with cognitive function and BMI in patients with schizophrenia?
In patients with schizophrenia, increased pro-inflammatory activity (HsCRP) is strongly correlated with higher BMI and impaired cognitive function.
Higher CRP was associated with impaired cognition in schizophrenia; cross-sectional design leaves causality and BMI role open for confirmation.
AIM: The objectives of the study were to determine the correlation between C-reactive protein (CRP) levels with cognitive function and body mass index (BMI) in a patient with schizophrenia. METHODS: This is a numerical correlative analytic study with a cross-sectional approach by means of nonprobability sampling with consecutive sampling with inclusion and exclusion criteria from August 2019 to November 2019 in the Prof. Dr. M. Ildrem Psychiatric Hospital in Province of North Sumatra after getting approval from the Research Ethics Committee at the Faculty of Medicine, University of North Sumatra. RESULTS: There is a very strong correlation in which Pearson correlation test between the high-sensitivity CRP (HsCRP) value with BMI and the Montreal cognitive assessment Versi Indonesia score in schizophrenic patients with a correlation coefficient value of r = 0.951 and r = –0.743, respectively, with a very strong correlation (p < 0.001). CONCLUSIONS: Increased pro-inflammatory activity, especially HsCRP may cause impaired cognitive function in people with schizophrenia.
No takes yet. Share an insight, caveat, or question.
Mahmuddin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: